TITLE

Cost-Effective Screening and Surveillance for Barrett Esophagus Are Limited to Patients with Dysplasia

AUTHOR(S)
Dysplasia Inadomi, J. M.; Sampliner, R.; Lagergren, J.
PUB. DATE
September 2004
SOURCE
Annals of Internal Medicine;9/7/2004, Vol. 141 Issue 5, p374
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
This article presents information on various gastroenterologic diseases. Although one-time screening endoscopy for Barrett esophagus is recommended for patients with gastroesophageal reflux disease (GERD), little evidence exists about the cost effectiveness of this practice. With as much as 10% of the population estimated to have GERD, many people need screening. The investigators found that screening for Barrett esophagus followed by surveillance limited to patients with Barrett esophagus and dysplasia was cost-effective, requiring $10 440 per quality-adjusted life-year saved compared with no screening or surveillance.
ACCESSION #
14563225

 

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics